- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
March 8, 2021Robins Kaplan LLP Announces 2021 Executive Board
-
March 4, 2021Robins Kaplan Files Class Action Against Martin Shkreli and His Former Companies on Behalf of Blue Cross and Blue Shield of Minnesota
-
March 1, 2021Amy Churan Named an Insurance Trailblazer by National Law Journal
-
March, 9, 2021The New Frontier of Software License Disputes
-
March 9, 2021Health Care Antitrust under President Biden
-
March 11, 2021Youth Frontiers’ 2021 Geometry of a Leader Conference
-
Winter 2021Pro Bono Publico–For The Public Good
-
Winter 2021The Case for Charitable Giving
-
Winter 2021The Fictional Wealth Disputes That We Took In and Learned From in 2020
-
March 8, 2021Financial Daily Dose 3.8.2021 | Top Story: Senate Passes $1.9 Trillion Covid Relief Bill
-
March 5, 2021Financial Daily Dose 3.5.2021 | Top Story: Powell Tries to Sooth Jumpy Markets Fearing Weak Jobs Report
-
March 4, 2021Financial Daily Dose 3.4.2021 | Top Story: Google Shakes Up Digital Ad Industry by Phasing Out Web Tracking
Jake Holdreith Named an Intellectual Property Trailblazer by The National Law Journal
July 5, 2017
Minneapolis, MN—July 5, 2017—Robins Kaplan LLP® is pleased to announce that Jake Holdreith, member of the Executive Board, has been named an Intellectual Property Trailblazer by The National Law Journal. This annual award recognizes the efforts of lawyers who are changing the ways in which IP is protected and managed, raising the bar on the practice of trademark, patent, and copyright law, and leading innovation in the field.
Over the course of his career, Holdreith has established himself as an innovative go-to patent litigator for generic pharmaceutical makers and technology companies alike. He has obtained multimillion-dollar verdicts for patent owners, including a $12 million settlement in Personal Audio LLC v. Apple Inc., where he persuaded a jury that Apple’s iPod infringed his client’s patents; a $25 million award after a jury found that Sony infringed four patents relating to digital camera technology in St. Clair Intellectual Property Consultants, Inc. v. Sony Corp. et al.; and a $34.7 million award in a similar action against Canon in St. Clair Intellectual Property Consultants, Inc. v. Canon, Inc. et al.
Holdreith has also secured defense wins including a summary judgement of non-infringement of 10 patents in Auxilium v. Upsher-Smith Labs; a trial judgment of invalidity of three patents in Purdue v. Actavis; an early dismissal of three patents in Purdue v. Collegium; and denial of an injunction after a bench trial, which later resulted in invalidity of the asserted patent, in Medicis Pharm. Corp. v. Upsher-Smith Labs.
Holdreith is also a recipient of the 2016 “Hatch-Waxman Impact Cases of the Year” award and was named a “Life Sciences Star” by LMG Life Sciences and a Notable Practitioner in Intellectual Property by Chambers USA.
The National Law Journal's 2017 Intellectual Property Trailblazers list is available here. Holdreith is the third Robins Kaplan partner to be named to the list since 2014.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.